Mr. Žunda has more than 16 years of experience with Sicor Biotech UAB, a leading biotech company in Central and Eastern Europe, and Teva Pharmaceutical Industries Ltd, the largest generic company in the world, where he steadily advanced within the organization. Under his leadership, the Vilnius site completed FDA inspections and commercialized products in both the EU and U.S. Most recently, he served as Site General Manager of Biologics Plant and member of the Board at Sicor Biotech UAB, Teva’s Lithuanian subsidiary. Mr. G. Žunda earned a Master’s degree from Vilnius Gediminas Technical University.
.svg)
